Back

GLP-1 agonists: how do they work?

26 August 2023 (11:20 - 11:35)
Organised by: Logo
Congress Presentation Part of: Pharma Made Easy Pharmacology and Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Ulrich Laufs

University Hospital Leipzig, Leipzig (Germany)

5 More presentations in this session

Presentation thumbnail
Lipid lowering agents: how to make optimal use of the full spectrum
Professor F. Mach (Geneva, CH)
Slides
Presentation thumbnail
Lipid lowering agents: how to make optimal use of the full spectrum - discussion
Presentation thumbnail
GLP-1 agonists: how do they work? - discussion
Presentation thumbnail
Antiplatelet drugs: clinically relevant details on the pharmacology of P2Y12 inhibitors
Professor S. Massberg (Munich, DE)
Slides
Presentation thumbnail
Antiplatelet drugs: clinically relevant details on the pharmacology of P2Y12 inhibitors - discussion

Access the full session

Session thumbnail
Pharma Made Easy

The Event

Event poster

ESC Congress 2023

26 August 2023 11:20 CET
You may be interested in
thumbnail
Webinar
GLP-1 RAs and HFpEF : what do we know from large RCTs about GLP-1 RAs and their effects on HFpEF?
24 November 2025
thumbnail
ESC Journals
Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node
4 June 2024
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes
28 August 2020
thumbnail
Congress Presentation
Effects of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, on lipid profiling in patients with type 2 diabetes
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources